Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) is a biopharmaceutical company that focuses on developing and acquiring technologies that aid in the discovery and development of medicines. The company operates in a competitive landscape with peers like Neurocrine Biosciences, Incyte Corporation, Alkermes plc, Myriad Genetics, and United Therapeutics Corporation.In evaluating Ligand's financial performance, the Return on Invested Capital (ROIC) is a critical metric. Ligand's ROIC is -3.48%, which is below ...